Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06954636

Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study

Sponsor: Sied Kebir

View on ClinicalTrials.gov

Summary

The study aims to investigate the prognostic significance of olfactory function in patients with glioblastoma. We are examining olfactory function at various points during therapy and correlating the results with survival data. In addition, neurocognitive tests will be carried out to correlate the results of olfactory function with the patient's cognitive abilities. Investigations into the quality of life and psychological condition of the patients are also performed. In addition to the cohort of glioblastoma patients, there is a control cohort without tumor disease in which the olfactory testing is also carried out in order to have a comparison.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

128

Start Date

2023-05-03

Completion Date

2028-12-31

Last Updated

2025-07-08

Healthy Volunteers

Yes

Interventions

DIAGNOSTIC_TEST

olfactory testing (threshold and identification test)

In the identification test, 12 sniffin sticks are presented, which the patient has to name using a selection card with four terms each. Both nostrils are tested individually at each visit during the identification test. A correct answer scores one point. A maximum of 12 points is possible. The threshold test consists of 16 dilution levels. Each level contains one sniffin stick with odor and two blanks. All three sniffin sticks of a dilution level are presented to the patient one after the other with eyes closed. The patient must indicate which of the three sticks contains an odor. Depending on whether the patient gives the correct answer, the three sniffin sticks in the next higher or next lower level are presented next. A maximum of 16 points is possible.

Locations (2)

University Hospital Essen, Department of Neurology, Division of Clinical Neuro-Oncology

Essen, Germany

Department of Neurosurgery

Münster, Germany